Bernstein Initiates Coverage of Novo Nordisk (NVO) With an Underperform Rating

Novo Nordisk A/S (NYSE:NVO) is one of the best undervalued stocks under $50 to invest in now. Bernstein initiated coverage of Novo Nordisk A/S (NYSE:NVO) with an Underperform rating and $175 price target on March 18. The firm told investors in a research note that the company’s earnings downgrade cycle is not over, adding that it believes Novo Nordisk’s (NYSE:NVO) catalyst path “looks bare.” It also said that the company’s weight loss drugs will underperform in the United States on lower volume share and m ...